Ictero Medical, Inc. has initiated a private equity offering, filing under Rule 506(b) to raise a total of $695,967. As of the filing date, the company has successfully secured $344,404 of this amount. This move is significant for Ictero Medical as it seeks to enhance its financial position and expand its operations.

Background

Ictero Medical, Inc. is a corporation based in Houston, Texas. The company was incorporated in Delaware and does not currently have any publicly traded tickers or exchanges listed. The firm specializes in the health care industry, categorized under Other Health Care. Recent filings include a private placement on November 5, 2026, and previous amendments in April and February of 2022.

What the Filing Says

The filing states, "Rule 506(b) provides a 'safer harbor' for a private offering." This indicates that the company is taking advantage of regulatory provisions to facilitate its fundraising efforts.

Impact

This offering may affect various stakeholders, including the nine investors who have already participated in the funding round. The move could also influence other companies in the health care sector, prompting them to consider similar private funding options.

What's Next

The filing does not say what happens next.

Company Details

Ictero Medical, Inc. is incorporated in Delaware and has been operational for over five years. The company is headquartered at 114 Holmes Rd., Suite 203, Houston, Texas, 77045. The business phone number is (415) 273-9648. The firm operates within the Other Health Care industry group.

Management Team

The executive team includes key individuals such as Manish Ahuja, who serves as both the CEO and an Executive Officer and Director. Other directors include John Fichthorn, Ashok Gowda, and Dr. Raymond Kirk, all of whom are based at the same Houston address as the company.

Investment Details

The offering allows for a minimum investment of $0, indicating that the company is open to various investment sizes. Notably, there are no sales commissions or finders' fees associated with this offering, which could be appealing to potential investors.

Offering Timeline

The filing specifies that the date of the first sale was October 1, 2026, and the offering is not expected to last more than one year. This timeline may influence the urgency for investors to participate in this fundraising round.

Financial Disclosures

The revenue range for Ictero Medical is currently undisclosed, which may raise questions for potential investors regarding the company's financial health. Additionally, the filing does not provide any information on the intended use of proceeds from the offering.